62 related articles for article (PubMed ID: 21530283)
1. In vitro studies of cellular response to DNA damage induced by boron neutron capture therapy.
Perona M; Pontiggia O; Carpano M; Thomasz L; Thorp S; Pozzi E; Simian M; Kahl S; Juvenal G; Pisarev M; Dagrosa A
Appl Radiat Isot; 2011 Dec; 69(12):1732-6. PubMed ID: 21530283
[TBL] [Abstract][Full Text] [Related]
2. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
3. Boron neutron capture therapy for undifferentiated thyroid carcinoma: preliminary results with the combined use of BPA and BOPP.
Viaggi M; Dagrosa MA; Longhino J; Blaumann H; Calzetta O; Kahl SB; Juvenal GJ; Pisarev MA
Appl Radiat Isot; 2004 Nov; 61(5):905-9. PubMed ID: 15308166
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
5. Studies for the application of boron neutron capture therapy to the treatment of differentiated thyroid cancer.
Dagrosa A; Carpano M; Perona M; Thomasz L; Nievas S; Cabrini R; Juvenal G; Pisarev M
Appl Radiat Isot; 2011 Dec; 69(12):1752-5. PubMed ID: 21570311
[TBL] [Abstract][Full Text] [Related]
6. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
Pisarev MA; Dagrosa MA; Thomasz L; Juvenal G
Medicina (B Aires); 2006; 66(6):569-73. PubMed ID: 17240633
[TBL] [Abstract][Full Text] [Related]
7. In vitro studies of DNA damage and repair mechanisms induced by BNCT in a poorly differentiated thyroid carcinoma cell line.
Rodriguez C; Carpano M; Curotto P; Thorp S; Casal M; Juvenal G; Pisarev M; Dagrosa MA
Radiat Environ Biophys; 2018 May; 57(2):143-152. PubMed ID: 29453554
[TBL] [Abstract][Full Text] [Related]
8. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
9. Early clinical trial concept for boron neutron capture therapy: a critical assessment of the EORTC trial 11001.
Wittig A; Collette L; Moss R; Sauerwein WA
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S59-62. PubMed ID: 19372041
[TBL] [Abstract][Full Text] [Related]
10. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
11. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
Dagrosa MA; Crivello M; Perona M; Thorp S; Santa Cruz GA; Pozzi E; Casal M; Thomasz L; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):262-8. PubMed ID: 20932650
[TBL] [Abstract][Full Text] [Related]
12. The radiation biology of boron neutron capture therapy.
Coderre JA; Morris GM
Radiat Res; 1999 Jan; 151(1):1-18. PubMed ID: 9973079
[TBL] [Abstract][Full Text] [Related]
13. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
15. In vitro neutron irradiation of glioma and endothelial cultured cells.
Menichetti L; Gaetano L; Zampolli A; Del Turco S; Ferrari C; Bortolussi S; Stella S; Altieri S; Salvadori PA; Cionini L
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S336-40. PubMed ID: 19410472
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells.
Faião-Flores F; Coelho PR; Arruda-Neto J; Maria DA
Appl Radiat Isot; 2011 Dec; 69(12):1741-4. PubMed ID: 21441034
[TBL] [Abstract][Full Text] [Related]
17. Monte Carlo simulation of the biological effects of boron neutron capture irradiation with d(14)+Be neutrons in vitro.
Pöller F; Sauerwein W
Radiat Res; 1995 Apr; 142(1):98-106. PubMed ID: 7899565
[TBL] [Abstract][Full Text] [Related]
18. Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
Packer S; Coderre J; Saraf S; Fairchild R; Hansrote J; Perry H
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):395-403. PubMed ID: 1740371
[TBL] [Abstract][Full Text] [Related]
19. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
20. Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
Bakeine GJ; Di Salvo M; Bortolussi S; Stella S; Bruschi P; Bertolotti A; Nano R; Clerici A; Ferrari C; Zonta C; Marchetti A; Altieri S
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S332-5. PubMed ID: 19394841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]